Topic - Biontech

Related Stories

Moderna CEO and Director Stephane Bancel arrives to testify to the Senate HELP Committee on the price of COVID-19 vaccine, Wednesday, March 22, 2023, on Capitol Hill in Washington. (AP Photo/Jacquelyn Martin)

Moderna CEO defends COVID vaccine price hike, citing pivot to endemic phase

By Tom Howell Jr. - The Washington Times

A Jackson-Hinds Comprehensive Health Center nurse loads a syringe with a Moderna COVID-19 booster vaccine at an inoculation station next to Jackson State University in Jackson, Miss., Friday, Nov. 18, 2022. Moderna recently announced early evidence that its updated booster induced BQ.1.1-neutralizing antibodies. (AP Photo/Rogelio V. Solis)

Vaccine makers pick Senate fight over soaring prices; fall boosters cost up to $130

By Tom Howell Jr. and Haris Alic - The Washington Times

In this Jan. 21, 2021, file photo a medical staff member prepares the Pfizer COVID-19 vaccine at Tudor Ranch in Mecca, Calif. With vaccination against COVID-19 in full swing, social platforms like Facebook, Instagram and Twitter say they’ve stepped up their fight against misinformation that aims to undermine trust in the vaccines. (AP Photo/Jae C. Hong, File)

‘Twitter Files’: Big Pharma pressured platform to censor COVID-19 vaccine debate

By Joseph Clark - The Washington Times

People visit the border of Hong Kong, with the skyline of China's Shenzhen in the background, in Hong Kong Feb. 13, 2021. Hong Kong will start to reopen its border with mainland China on Sunday, Jan. 8, 2023, allowing tens of thousands of people to travel between both sides each day under a quarantine-free arrangement, the city's leader said Thursday, Jan. 5. (AP Photo/Kin Cheung, File)

Hong Kong residents rush to get vaccinated for COVID, fearing mainland influx

By Tom Howell Jr. - The Washington Times

Illustration on Congrsssional price controls on prescription drugs and the resulting unfair benefits to bigger biotech companies by Alexander Hunter/The Washington Times

Price controls in the Inflation Reduction Act will drive small biotechs out of business

By Karen Kerrigan

FILE - Syringes and colorful bandages are prepared as children from local schools prepare to get COVID-19 vaccines in Pittsfield, Mass., on Monday Dec. 13, 2021. A review by federal health officials finds that Pfizer's COVID-19 vaccine appears safe and effective for children under 5, the only group not currently eligible for vaccination. The review issued Sunday, June 12, 2022, by the Food and Drug Administration is a key step toward a decision on vaccinations for babies, toddlers and preschoolers, perhaps as soon as June 21. (Ben Garver/The Berkshire Eagle via AP, File)

Pfizer, BioNTech now siccing experimental COVID shots on babies

By Cheryl K. Chumley - The Washington Times

Deborah Sampson, left, a nurse at a University of Washington Medical Center clinic in Seattle, gives a Pfizer COVID-19 vaccine shot to a 20-month-old child, June 21, 2022, in Seattle. Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5. The youngest tots already are supposed to get three extra-small doses of the original vaccine as their primary series. Pfizer and its partner BioNTech said Monday, Dec. 5, 2022 that if the Food and Drug Administration agrees, the updated vaccine would be used for the third shot. The FDA already has cleared COVID-19 vaccines tweaked to better target omicron as boosters for everyone 5 and older. (AP Photo/Ted S. Warren, file)

Pfizer asks FDA to clear updated COVID shot for kids under 5

By Lauran Neergaard - Associated Press

A COVID vaccine, left, is readied as a flu vaccine sits nearby at the L.A. Care and Blue Shield of California Promise Health Plans' Community Resource Center where they were offering members and the public free flu and COVID-19 vaccines Friday, Oct. 28, 2022, in Lynwood, Calif. (AP Photo/Mark J. Terrill)

Pfizer, Moderna work on a single shot for flu and COVID-19

By Tom Howell Jr. - The Washington Times

Pfizer study says updated COVID boosters rev up protection

By Lauran Neergaard - Associated Press

A syringe is placed into a vial of Pfizer-BioNTech vaccination at a COVID-19 clinic in Augusta, Maine, on Tuesday, Dec. 21, 2021. On Thursday, Oct. 20, 2022, Pfizer said it will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving doses for free. (AP Photo/Robert F. Bukaty, File)

COVID-19 vaccine side effects like chills, fever are signs of good antibody response: paper

By Tom Howell Jr. - The Washington Times

This August 2022 photo provided by Pfizer shows vials of the company's updated COVID-19 vaccine during production in Kalamazoo, Mich. U.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain. The move on Wednesday, Aug. 13, 2022, by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. (Pfizer via AP)

Should you get a new COVID booster? If so, when?

By Lauran Neergaard - Associated Press

A pharmacist injects a patient with a booster dosage of the Moderna COVID-19 vaccine at a vaccination clinic in Lawrence, Mass., on Wednesday, Dec. 29, 2021. U.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain. The move on Wednesday, Aug. 13, 2022, by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. (AP Photo/Charles Krupa) **FILE**

U.S. clears updated COVID boosters targeting newest variants

By Lauran Neergaard - Associated Press

A Jackson, Miss., resident receives a Pfizer booster shot from a nurse at a vaccination site Tuesday, Feb. 8, 2022. In August 2022, Pfizer and Moderna both asked U.S. regulators to authorize modified versions of their booster vaccine — shots that are half the original recipe and half protection against BA.4 and BA.5, the newest subtypes of the coronavirus omicron variant. (AP Photo/Rogelio V. Solis, File)

Tweaked COVID boosters close but how much will they help?

By Lauran Neergaard - Associated Press

A health worker administers a dose of a Pfizer COVID-19 vaccine during a vaccination clinic in Reading, Pa., Sept. 14, 2021. Pfizer asked U.S. regulators Monday, Aug. 22, 2022, to authorize its combination COVID-19 vaccine that adds protection against the newest omicron mutants — a key step toward opening a fall booster campaign. (AP Photo/Matt Rourke, File)

Pfizer seeks OK of updated COVID vaccine booster for fall

By Lauran Neergaard - Associated Press

Nora Burlingame, 3, is given a Pfizer COVID-19 vaccine shot, Tuesday, June 21, 2022, at a University of Washington Medical Center clinic in Seattle. COVID-19 shots for children between six months and five years of age were given federal authorization over the weekend. (AP Photo/Ted S. Warren)

COVID shots for tots flop despite Biden’s push

By Susan Ferrechio - The Washington Times